IRON Relative Valuation
IRON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IRON is overvalued; if below, it's undervalued.
Historical Valuation
Disc Medicine Inc (IRON) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -10.97. The fair price of Disc Medicine Inc (IRON) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：92.66
Fair
-14.51
PE
1Y
3Y
5Y
Trailing
Forward
-12.16
EV/EBITDA
Disc Medicine Inc. (IRON) has a current EV/EBITDA of -12.16. The 5-year average EV/EBITDA is -6.86. The thresholds are as follows: Strongly Undervalued below -10.86, Undervalued between -10.86 and -8.86, Fairly Valued between -4.86 and -8.86, Overvalued between -4.86 and -2.86, and Strongly Overvalued above -2.86. The current Forward EV/EBITDA of -12.16 falls within the Strongly Undervalued range.
-10.97
EV/EBIT
Disc Medicine Inc. (IRON) has a current EV/EBIT of -10.97. The 5-year average EV/EBIT is -7.49. The thresholds are as follows: Strongly Undervalued below -12.08, Undervalued between -12.08 and -9.79, Fairly Valued between -5.19 and -9.79, Overvalued between -5.19 and -2.90, and Strongly Overvalued above -2.90. The current Forward EV/EBIT of -10.97 falls within the Undervalued range.
196.71
PS
Disc Medicine Inc. (IRON) has a current PS of 196.71. The 5-year average PS is 474.36. The thresholds are as follows: Strongly Undervalued below -2743.92, Undervalued between -2743.92 and -1134.78, Fairly Valued between 2083.51 and -1134.78, Overvalued between 2083.51 and 3692.65, and Strongly Overvalued above 3692.65. The current Forward PS of 196.71 falls within the Historic Trend Line -Fairly Valued range.
-15.54
P/OCF
Disc Medicine Inc. (IRON) has a current P/OCF of -15.54. The 5-year average P/OCF is -10.85. The thresholds are as follows: Strongly Undervalued below -17.48, Undervalued between -17.48 and -14.16, Fairly Valued between -7.54 and -14.16, Overvalued between -7.54 and -4.23, and Strongly Overvalued above -4.23. The current Forward P/OCF of -15.54 falls within the Undervalued range.
-17.96
P/FCF
Disc Medicine Inc. (IRON) has a current P/FCF of -17.96. The 5-year average P/FCF is -12.71. The thresholds are as follows: Strongly Undervalued below -21.18, Undervalued between -21.18 and -16.94, Fairly Valued between -8.47 and -16.94, Overvalued between -8.47 and -4.23, and Strongly Overvalued above -4.23. The current Forward P/FCF of -17.96 falls within the Undervalued range.
Disc Medicine Inc (IRON) has a current Price-to-Book (P/B) ratio of 5.64. Compared to its 3-year average P/B ratio of 3.29 , the current P/B ratio is approximately 71.69% higher. Relative to its 5-year average P/B ratio of 3.29, the current P/B ratio is about 71.69% higher. Disc Medicine Inc (IRON) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -6.60%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -6.60% , the current FCF yield is about -100.00% lower.
5.73
P/B
Median3y
3.29
Median5y
3.29
-4.76
FCF Yield
Median3y
-6.60
Median5y
-6.60
Competitors Valuation Multiple
The average P/S ratio for IRON's competitors is 7.32, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IRON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IRON in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is Disc Medicine Inc (IRON) currently overvalued or undervalued?
What is Disc Medicine Inc (IRON) fair value?
How does IRON's valuation metrics compare to the industry average?
What is the current P/B ratio for Disc Medicine Inc (IRON) as of Dec 05 2025?
What is the current FCF Yield for Disc Medicine Inc (IRON) as of Dec 05 2025?
What is the current Forward P/E ratio for Disc Medicine Inc (IRON) as of Dec 05 2025?